Dual targeting of VEGFR2 and CSF1R with SYHA1813 confers novel strategy for treating both BRAF wild-type and mutant melanoma.
SYHA1813 双重靶向 VEGFR2 和 CSF1R 为治疗 BRAF 野生型和突变型黑色素瘤提供了一种新的策略
期刊:Cancer Cell International
影响因子:6
doi:10.1186/s12935-025-03902-y
Shi Wenhao, Tang Haotian, Tong Linjiang, Song Peiran, Huang Yuqing, Wan Zhipeng, Huang Gege, Liu Qiupei, Zhan Zhengsheng, Zhou Yu, Li Yuantong, Wen Jiaxin, Tang Bencan, Duan Wenhu, Ding Jian, Li Xiaorui, Xie Hua
